Global Premieres at CIIE: 15-Minute Precision Radiotherapy, Photon-Counting CT, and More Breakthrough Medical Innovations

At the 4th China International Import Expo (CIIE), within the 70,000-square-meter exhibition area for medical devices and healthcare products, the number of new products and technologies making their debut or first-time exhibition far exceeded that of the previous three editions. Multiple participating enterprises expressed recognition of the CIIE's spillover effect.

What distinctive medical and healthcare exhibits and debut “new technologies” will be showcased this year? Follow 《International Financial News》 reporters for a firsthand experience!

Varian: Three Major "Global Debut" Solutions

As an "old friend" that has participated in the CIIE for four consecutive editions, Varian Medical Systems (a member of Siemens Healthineers) is showcasing three "global debut" solutions at this year's CIIE.

Varian is exhibiting a full-scale ProBeam 360° treatment room on-site. At 60 cubic meters, it will be the largest exhibit by volume in the medical pavilion, allowing visitors to experience firsthand the power of proton beams accelerated to 160,000 km/s to deliver near-ideal "pinpoint ablation" to tumor sites. Featuring exceptional performance with an ultra-high dose rate and ultra-high precision, the ProBeam 360° system reduces its footprint by 30%, volume by 50%, and construction costs by 25%. This compact design aims to advance the widespread adoption of proton therapy.

Meanwhile, it launched the world's first highly automated, AI-driven contactless cancer radiotherapy center.

Centered on Ethos, the world’s first Adaptive Intelligence solution, the center accurately tracks dynamically changing tumor targets to deliver real-time, personalized precision radiotherapy. Powered by cutting-edge AI-driven technologies such as automated target delineation and automated treatment planning, it completes online precision radiotherapy workflows in just 15 minutes—a process that traditionally requires up to 10 hours. This marks the first commercial application of AI to integrate the entire adaptive radiotherapy workflow, all conducted within a completely contact-free, safe clinical environment.

Additionally, the digital oncology internet hospital solution was launched globally for the first time.

This program is an integrated online-to-offline full-process service platform that combines internet technology with advanced medical practices and resources. Built upon the innovative practice of "Internet + Oncology Treatment," it delivers a comprehensive suite of extended services covering early screening and diagnosis, remote online expert consultations, oncology multidisciplinary team (MDT) consultations, cancer treatment, real-time home follow-up for patients, and cancer health education. It transforms the traditionally segmented pre-diagnosis, in-treatment, and post-treatment service model, establishing a new paradigm and ecosystem for full-cycle healthcare management. The platform provides cancer patients with multidimensional, standardized, and continuous personalized treatment services throughout their entire care journey. It effectively mitigates the uneven distribution of high-quality oncology diagnostic and therapeutic resources, thereby making patient consultations more convenient and emergency oncology care services more efficient.

Thermo Fisher Scientific: Three New Products Make Their Debut

Thermo Fisher Scientific (hereinafter referred to as "Thermo Fisher") has participated in the China International Import Expo (CIIE) for four consecutive years. At this CIIE, Thermo Fisher set up exhibition booths in both the Medical Devices & Healthcare zone in Hall 8.1 and the Biopharmaceuticals zone in Hall 7.2, showcasing its innovative technologies and solutions spanning multiple sectors, including healthcare and biopharmaceuticals. Over the four days since the expo's opening, both booths have been bustling with large crowds, with a diverse product portfolio highlighting Thermo Fisher's world-class innovative technologies and solutions.

At the exhibition, Thermo Fisher Scientific also established partnerships with local partners from multiple sectors, including biopharmaceuticals and life sciences.

Thermo Fisher Scientific unveiled three debut products, demonstrating exceptional capabilities in disease screening and diagnosis, disease treatment, and biopharmaceuticals.

Making its global debut at this CIIE, the Gibco CTS Xenon large-capacity cell electroporation system is purpose-built for cell therapy applications, enabling complex gene editing and achieving transfection and gene editing efficiencies of up to 90% in hard-to-modify immune cells; it can complete gene delivery for 2.5 × 10⁹ T cells within 25 minutes.

Thermo Fisher Scientific has launched the Thermo Scientific HyPeak Chromatography System for the first time in Asia. Designed for downstream chromatography unit operations in biopharmaceutical manufacturing, the system innovatively incorporates single-use technology to provide open, flexible, and efficient support for antibody drug and viral vector process development, as well as cGMP production scale-up.

Additionally, the Applied Biosystems QuantStudio Absolute Q digital PCR system, first launched in China, is a chip-based digital PCR system widely used in residual host DNA detection, viral titer determination, copy number quality control for cell and gene therapy, and companion diagnostics for tumor markers, offering higher sensitivity and precision compared to quantitative fluorescent PCR.

Medtronic: Global Debut of the Evolut FX TAVR System

On November 6, multiple innovative products were showcased at Medtronic's CIIE booth, including the Evolut FX TAVR System making its global debut, the DiamondTemp Ablation System—a diamond-tip temperature-controlled cooled saline irrigation radiofrequency ablation system—making its Asian debut, and the "world's thinnest drug-eluting stent," Resolute Onyx DES.

Taking the Evolut FX as an example, this is Medtronic's latest-generation transcatheter aortic valve replacement (TAVR) system, indicated for the treatment of severe aortic stenosis, which received U.S. Food and Drug Administration (FDA) approval in August 2021. The standout feature of this product is that it is the world's only transcatheter valve utilizing gold as radiopaque markers, enabling clear visualization throughout the implantation procedure and thereby making "valve replacement without open-chest surgery" more precise and safer.

Gu Yushao, Global Senior Vice President and President of Greater China at Medtronic, stated that, based on the spillover effects of previous CIIEs, the early exhibition of products at the expo, coupled with demonstrations and communications with customers, partners, and regulatory authorities, has indeed accelerated the market launch process of related products.

KaVo Group: Three Major Digital Innovative Products

On November 7, KaVo Group made its debut at the China International Import Expo (CIIE) with three major digital innovative products: the DTXStudio™ Digital Clinical Ecosystem System, the X-Guide™ 3D Dynamic Implant Navigation System, and the newly upgraded Spark™ Clear Aligner System.

The DTXStudio™ Digital Diagnosis and Treatment Ecosystem (abbreviated as DTX) is an intelligent clinical software making its Asian debut at this CIIE by the KaVo Group. It elevates KaVo Group’s “one-stop solution” to a “one-stop digital solution.” By seamlessly interconnecting every step of the entire workflow, it unifies all data required for clinical diagnosis and treatment into a single platform and consolidates multiple operational software applications into one, significantly enhancing dental clinical efficiency while delivering a precise and predictable treatment experience.

Making its Asian debut at the China International Import Expo (CIIE), the X-Guide 3D dynamic implant navigation system (abbreviated as X-Guide) functions like a GPS navigation system for dental implant surgery, providing real-time, interactive, and dynamic tracking and positioning throughout the entire procedure. It enables surgeons to obtain precise, continuous guidance on implant placement, angulation, and depth, facilitating immediate minimally invasive surgery and delivering broader, more standardized, and more precise dental implant services.

The China debut of the newly upgraded Spark Clear Aligner System elevates orthodontic treatment to new heights of precision, safety, and predictability. The innovative TruGEN material achieves threefold discretion in orthodontics: visual invisibility, tactile comfort, and procedural discretion. The newly upgraded Approver R11 root and bone analysis software delivers authentic 3D root comparison analysis, safeguarding the safety of every step of tooth movement.

A representative of the KaVo Group stated that, moving forward, the Group will continue to increase its investment in the Chinese market. While accelerating the introduction of innovative global products and fostering domestic and international academic exchanges, KaVo will enhance local R&D and manufacturing capabilities, deepen industry-academia-research collaboration within China, and vigorously drive the innovative upgrading of China's full dental industry chain ecosystem.

Siemens Healthineers: Angiography System World Premiere

At this year's CIIE, Siemens Healthineers showcased its debut products and innovative technologies spanning oncology diagnosis and treatment, telemedicine, and public health infrastructure development.

During this period, Siemens Healthineers' new ARTIS pheno 2.0 angiography system made its China debut.

Siemens Healthineers' world's first FDA-approved photon-counting CT technology with semiconductor detectors makes its simultaneous global debut. Utilizing semiconductor detectors fabricated from novel cadmium telluride (CdTe) crystals, photon counting directly detects each individual X-ray photon and precisely quantifies the energy signals carrying vital information about the human body. The paradigm-shifting breakthrough of photon-counting technology lies in transforming "computational estimation" into "direct counting measurement," thereby restoring the true material properties to the greatest extent possible.

Huang Yi, Vice President of Imaging Diagnostics Systems at Siemens Healthineers Greater China, stated that while cadmium telluride takes three million years to form in nature, it only takes three months to grow pure crystals in Siemens Healthineers’ detector laboratory. During the growth process, the laboratory maintains an ultra-cleanroom environment, thereby ensuring the absolute purity and performance of the crystals.

Philips: World's First! Next-Generation Photon-Counting CT

Royal Philips has participated in the China International Import Expo (CIIE) for four consecutive years. This year, the Philips booth has been comprehensively upgraded under the theme "Advancing Technology for Boundless Health," with the entire exhibition space divided into "four major zones."

At this year's CIIE, the world's first spectral photon-counting CT makes its Asian debut, leading CT technology into a new realm of multi-energy multi-parametric imaging and ushering in the era of Color CT Wide-Coverage 2.0. Philips' next-generation spectral photon-counting CT, the Spectral CT 7500, leverages cutting-edge spectral photon-counting imaging technology for precise material decomposition. It enables accurate localization and characterization of ultra-early lesions, and supports advanced clinical applications such as one-stop cardiovascular morphological and functional imaging, precision oncology, emergency trauma care, and premium health management. Furthermore, it significantly enhances diagnostic accuracy and reliability, while optimizing the efficiency of healthcare resource utilization.

This year, Philips continues to focus on the "health continuum," covering healthy living, disease prevention, precision diagnosis, interventional therapy, and home care.

Smith & Nephew: PICO 7 Officially Launched

At the 4th China International Import Expo, Smith & Nephew showcased its globally leading PICO7 single-use negative pressure wound therapy system and dressing. Approved for the Chinese market earlier this year, it was officially launched at the expo.

For chronic wounds caused by conditions such as diabetic foot ulcers and pressure ulcers, traditional wound dressings require frequent changes, causing patient discomfort and high costs; whereas the use of exudate collection canisters restricts mobility.

The core wound-contact dressing of the PICO7 consists of four layers, with one end connected to a palm-sized disposable negative pressure unit. Pressing the button on the device instantly transforms the dressing into a breathing, super "cupping" system: it evenly distributes negative pressure across the entire area beneath the dressing, uniformly absorbs wound exudate, and meanwhile, the highly breathable polyurethane top film facilitates the continuous and efficient evaporation of moisture beneath the dressing.

PerkinElmer: Launch of One-Stop Platform for Innovative Vaccine R&D

PerkinElmer’s Innovative One-Stop Vaccine R&D Platform Makes Its Asia Debut, with Applications in Vaccine R&D, Analysis, and Evaluation, Significantly Accelerating the Development and Clinical Testing Processes for Both Novel and Conventional Vaccines.

The platform can flexibly integrate multiple systems based on application requirements, comprehensively supporting critical areas in vaccine R&D, including neutralizing antibody testing, antibody functional analysis, vaccine potency evaluation, and vaccine quality control. Its advantages lie in full automation, high throughput, and flexibility, with a daily processing capacity of over 30,000 samples. Additionally, it is compatible with various major technological platforms currently utilized in vaccine development, garnering significant attention in the current pandemic era.

Accuray: Debut of Multiple High-Tech Products

At the 4th China International Import Expo, multiple high-tech products made their China debut, with Accuray's next-generation CyberKnife robotic radiosurgery system and the CT-guided synchronized tracking helical tomotherapy system making their Asia-Pacific debut.

It is reported that the Synchronous Tracking Helical Tomotherapy System, through optimized automated tumor motion tracking and real-time beam correction technology, has resolved the industry challenge of accurate beam delivery for tumors affected by respiratory motion, such as lung cancer, enabling uninterrupted precision radiotherapy under free-breathing conditions.

FANCL: "Collagen Jelly" Debuts at CIIE

This year, reporters at the FANCL booth in Japan discovered two "beauty jellies" that are not only pleasantly chewy and bouncy with a sweet-and-sour flavor, but also help supplement collagen.

At the CIIE, FANCL showcased three products making their "Asian debut." In addition to the jelly series, there is also a dietary supplement named "Internal Fat Support," which primarily works by regulating the intestinal environment and promoting fat metabolism to achieve control over body weight and body fat. The product's standout feature is the company's proprietary dual acid-resistant capsule technology, which protects 15 billion bifidobacteria from gastric acid degradation, ensuring the live bacteria remain viable until they reach the intestines to exert their beneficial effects.